These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21045016)

  • 1. Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells.
    Tang SW; Yang TC; Lin WC; Chang WH; Wang CC; Lai MK; Lin JY
    Carcinogenesis; 2011 Feb; 32(2):138-45. PubMed ID: 21045016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription.
    Wang CH; Chang HC; Hung WC
    J Cell Physiol; 2006 Jul; 208(1):246-52. PubMed ID: 16575904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Park CM; Park MJ; Kwak HJ; Lee HC; Kim MS; Lee SH; Park IC; Rhee CH; Hong SI
    Cancer Res; 2006 Sep; 66(17):8511-9. PubMed ID: 16951163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway.
    Cheng JC; Chou CH; Kuo ML; Hsieh CY
    Oncogene; 2006 Nov; 25(53):7009-18. PubMed ID: 16732316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13.
    Hou CH; Hsiao YC; Fong YC; Tang CH
    Bone; 2009 Feb; 44(2):233-42. PubMed ID: 19038372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1.
    Bae IH; Park MJ; Yoon SH; Kang SW; Lee SS; Choi KM; Um HD
    Cancer Res; 2006 May; 66(10):4991-5. PubMed ID: 16707418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential.
    Miyake H; Hara I; Gohji K; Yamanaka K; Hara S; Arakawa S; Nakajima M; Kamidono S
    Clin Cancer Res; 1999 Oct; 5(10):2824-9. PubMed ID: 10537348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
    Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
    Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2.
    Choi J; Choi K; Benveniste EN; Rho SB; Hong YS; Lee JH; Kim J; Park K
    Cancer Res; 2005 Jul; 65(13):5554-60. PubMed ID: 15994927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets.
    Ding Y; Huang D; Zhang Z; Smith J; Petillo D; Looyenga BD; Feenstra K; Mackeigan JP; Furge KA; Teh BT
    Cancer Res; 2011 Aug; 71(15):5225-34. PubMed ID: 21642374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-Adenosylhomocysteine promotes the invasion of C6 glioma cells via increased secretion of matrix metalloproteinase-2 in murine microglial BV2 cells.
    Lin HC; Song TY; Hu ML
    Toxicol Sci; 2009 Dec; 112(2):322-30. PubMed ID: 19770485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indole-3-carbinol inhibits Sp1-induced matrix metalloproteinase-2 expression to attenuate migration and invasion of breast cancer cells.
    Hung WC; Chang HC
    J Agric Food Chem; 2009 Jan; 57(1):76-82. PubMed ID: 19061309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis.
    Xie TX; Wei D; Liu M; Gao AC; Ali-Osman F; Sawaya R; Huang S
    Oncogene; 2004 Apr; 23(20):3550-60. PubMed ID: 15116091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CX3CR1 associates with cellular migration, metastasis, and prognosis in human clear cell renal cell carcinoma.
    Yao X; Qi L; Chen X; Du J; Zhang Z; Liu S
    Urol Oncol; 2014 Feb; 32(2):162-70. PubMed ID: 23570708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
    Ohba K; Miyata Y; Koga S; Kanda S; Kanetake H
    Urology; 2005 May; 65(5):1029-34. PubMed ID: 15882758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between expression of matrix metalloproteinase-9 (MMP-9) and angiogenesis in renal cell carcinoma].
    Zhang Y; Wu XH; Cao GH; Li S
    Ai Zheng; 2004 Mar; 23(3):326-9. PubMed ID: 15025968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
    Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
    Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.